Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lister-James

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Small peptides radiolabeled with 99mTcJ Lister-James, B R Moyer, T Dean
International Archives of Allergy and Immunology|May 4, 1999
In vivo leukocytes labeling using a platelet factor 4-derived heparin binding peptide technetium complexC F Nicodemus, B R Moyer, J Lister-James
Chest|May 16, 2000
A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodulesJ Blum, H Handmaker, J Lister-James, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1997
Pharmacokinetic considerations in the development of peptide-based imaging agentsJ Lister-James, B R Moyer, R T Dean
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 29, 2000
Acute thromboscintigraphy with (99m)Tc-apcitide: results of the phase 3 multicenter clinical trial comparing 99mTc-apcitide scintigraphy with contrast venography for imaging acute DVT. Multicenter Trial InvestigatorsR Taillefer, S Edell, G Innes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1984
A comparison of two cerebral perfusion tracers, N-isopropyl I-123 p-iodoamphetamine and I-123 HIPDM, in the humanB L Holman, R G Lee, T C Hill, et al.
Bioconjugate Chemistry|November 1, 1990
Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugateR W Weber, R H Boutin, M A Nedelman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1986
Effect of reperfusion and hyperemia on the myocardial distribution of technetium-99m t-butylisonitrileB L Holman, C A Campbell, J Lister-James, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1988
Hexakis(carbomethoxyisopropylisonitrile) technetium(I), a new myocardial perfusion imaging agent: binding characteristics in cultured chick heart cellsD Piwnica-Worms, J F Kronauge, B L Holman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1984
I-123 HIPDM brain imaging with a rotating gamma camera and slant-hole collimatorJ F Polak, B L Holman, J L Moretti, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|September 1, 1996
Small peptides radiolabeled with 99mTcJ Lister-James, B R Moyer, T Dean
International Archives of Allergy and Immunology|May 4, 1999
In vivo leukocytes labeling using a platelet factor 4-derived heparin binding peptide technetium complexC F Nicodemus, B R Moyer, J Lister-James
Chest|May 16, 2000
A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodulesJ Blum, H Handmaker, J Lister-James, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1997
Pharmacokinetic considerations in the development of peptide-based imaging agentsJ Lister-James, B R Moyer, R T Dean
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 29, 2000
Acute thromboscintigraphy with (99m)Tc-apcitide: results of the phase 3 multicenter clinical trial comparing 99mTc-apcitide scintigraphy with contrast venography for imaging acute DVT. Multicenter Trial InvestigatorsR Taillefer, S Edell, G Innes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1984
A comparison of two cerebral perfusion tracers, N-isopropyl I-123 p-iodoamphetamine and I-123 HIPDM, in the humanB L Holman, R G Lee, T C Hill, et al.
Bioconjugate Chemistry|November 1, 1990
Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugateR W Weber, R H Boutin, M A Nedelman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1986
Effect of reperfusion and hyperemia on the myocardial distribution of technetium-99m t-butylisonitrileB L Holman, C A Campbell, J Lister-James, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1988
Hexakis(carbomethoxyisopropylisonitrile) technetium(I), a new myocardial perfusion imaging agent: binding characteristics in cultured chick heart cellsD Piwnica-Worms, J F Kronauge, B L Holman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1984
I-123 HIPDM brain imaging with a rotating gamma camera and slant-hole collimatorJ F Polak, B L Holman, J L Moretti, et al.
Pageof 3